AI In Pharma Market 2021 - By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule and Large Molecule), By Application (Clinical Trial Research, Drug Discovery, Research And Development), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $4000.00 | Pages : 257 | Published : September 2021 | SKU CODE : | Format :

Request Sample

AI In Pharma Market Definition

The artificial intelligence (AI) in pharma market consists of sales of AI software products in the pharma and related services that use an automated algorithm to perform tasks that traditionally rely on human intelligence. It can be useful in handling data and presenting results that encourage better decision-making and save human efforts, cost, and time.

Artificial intelligence (AI) is concerned with the simulation of human intelligence in machines which are programmed to think like humans and mimic their actions. Artificial Intelligence in pharma refers to the system of interconnected and automated technologies in the pharmaceuticals and biotechnology industry that can function autonomously, with little or no human intervention. It is helping pharmaceutical companies to improve clinical trials, enable predictive power in the R&D process and has the ability to elevate pharma manufacturing.

AI In Pharma Market Size

The global AI in pharma market reached a value of nearly $699.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 31.8 % since 2015. The market is expected to grow from $699.3 million in 2020 to $2,895.5 million in 2025 at a rate of 32.9%. The AI in pharma market is then expected to grow at a CAGR of 25.9% from 2025 and reach $9,142.7 million in 2030.  

Growth in the historic period in the AI in pharma market resulted from increased healthcare expenditure, strong economic growth in emerging markets, and government initiatives in developing economies. The market was restrained skilled workers, low healthcare access, and challenges due to regulatory changes.

Going forward growing adoption of artificial intelligence (AI) for clinical trials, increasing use of artificial intelligence (AI) for tracking medication adherence, and COVID-19 will drive the growth in the AI in pharma market. Factors that could hinder the growth of the market in the future include intense competition and incompatible legacy health IT infrastructure.

AI In Pharma Market Drivers

The key drivers of the AI in pharma market included:

Growing Adoption Of Artificial Intelligence (AI) For Clinical Trials

To bring a new drug to the market takes on an average 10-15 years approximately and half of this time is consumed during the clinical trial phases of the drug development cycle. Hence, using AI models and analytics tools can accelerate the clinical trial phases, perception of diseases, identify suitable cases and key investigators to inform site selection, and support novel clinical study designs. For instance, in January 2020, Pfizer, an American pharmaceutical company, tied up with a biotech startup Insilico Medicine to identify drug targets. With AI tools Pfizer can speed up drug discovery and reduce drug development costs in the drug development processes. Thus, increasing the adoption of AI for clinical trials research is driving AI in the pharma market.

AI In Pharma Market Restraints

The key restraints on the AI in pharma market include:

Intense Competition

The AI in pharma market is expected to be limited due to high competition in terms of pricing, product portfolio and other factors from market competitors and new entrants in the market, during the forecast period. Existing players in the market are offering a wider range of products at competitive process to increase their customer base and boost revenues. A large number of start-up companies are also developing innovative products. As most of these start-ups are funded by venture capital companies, they have sufficient capital for research and development of new software products. Furthermore, the increase in competitors in the market is likely to result in price-wars. This would affect the sales of companies, resulting in lower revenues and profit margins. These price-wars further affect the funding available for research and development projects, this limits the launch of new products, thereby having a negative impact on the market growth.

AI In Pharma Market Trends

Major trends shaping the AI in pharma market include the following –

Use Of AI For Clinical Trials

Companies in the AI in pharma market are leveraging AI for clinical trials. AI can be used to make sense of the vast amount of patient, research, and diagnostic data which is gathered every day. In silico experiments are conducted by means of a computer simulation by running drug trials on computer simulations of organs, this technology is capable of completely bypassing in vivo clinical testing. These trials not only save time and are cost effective, but they also completely circumvent animal testing and side effects on human and animal participants. For instance, France based Novadiscovery uses AI to run clinical trial simulations to build diseases models in the preclinical phase. AI can also be used to find the patients to take the drugs. For instance, companies such as Deep6 and Antidote, use AI algorithms to parse, analyze, and interpret health data thus streamlining the patient selection process. The platforms analyze structured and unstructured data to match patients and trials and identifies clinical trials most suitable for the patient.

AI For Rare Diseases Treatment

Companies in the AI in pharma market are developing drugs for rare diseases through advancements in AI. The technology is being used to develop personalized drug treatments based on an individual’s genes, environment, and lifestyle. For instance, in 2019, UK-based biotech firm, Healx secured a $56 million funding to use AI to develop innovative drugs for rare conditions such as the fragile X syndrome.  AI is also being used for diagnosis of rare diseases so that the proper line of treatment can be started quickly. For instance, Israel based Emedgene has a platform which can not only scan the DNA data file of a patient with a rare disease, but can also use natural language processing (NLP) to read the up-to-date medical literature. This allows the platform to find documented connections between a patient’s genetic variants and their condition, helping speed up the diagnosis.

Opportunities And Recommendations In AI Pharma Market

Opportunities –The top opportunities in the AI in pharma market segmented by technology will arise in the deep learning segment, which will gain $721.5 million of global annual sales by 2025. The top opportunities in the AI in pharma market segmented by drug type will arise in small molecules segment, which will gain $1,298.9 million of global annual sales by 2025. The top opportunities in the AI in pharma market segmented by application will arise in drug discovery segment, which will gain $1,710.0 million of global annual sales by 2025.  The AI in pharma market size will gain the most in the USA at $665.1 million.

Recommendations-To take advantage of these opportunities, The Business Research Company recommends the AI in pharma companies should focus on investing in AI innovation labs and use AI technology for developing drug for rare diseases to reduce the disease burden, establishing operations in emerging markets to gain market share, scale up through mergers and acquisition, focus on offering competitive pricing, increase visibility through websites and focus on end-user industries among other strategies.

AI In Pharma Market Segmentation

The AI in pharma market is segmented by technology, by end use industry and by mode.
By Technology-
The AI in pharma market is segmented by technology into
    • a. Context-Aware Processing
    • b. Natural Language Processing
    • c. Querying Method
    • d. Deep Learning
The deep learning was the largest segment of the AI in pharma market segmented by technology, accounting for 33.2% of the total in 2020. Going forward, the querying method segment is expected to be the fastest growing segment in the AI in pharma market segmented by technology, at a CAGR of 32.74% during 2020-2025.
By Drug Type –
The AI in pharma market is segmented by drug type into
    • a. Small Molecule
    • b. Large Molecule
The small molecules market was the largest segment of the AI in pharma market segmented by drug type, accounting for 65.4% of the total in 2020. Going forward, large molecules segment is expected to be the fastest growing segment in the AI in pharma market segmented by drug type, at a CAGR of 36.3% during 2020-2025.
By Application –
The AI in pharma market is segmented by application into
    • a. Clinical Trial Research
    • b. Drug Discovery
    • c. Research And Development
    • d. Others
The drug discovery was the largest segment of the AI in pharma market segmented by application, accounting for 80.4% of the total in 2020. Going forward, clinical trial research segment is expected to be the fastest growing segment in the AI in pharma market segmented by application, at a CAGR of 37.8% during 2020-2025.
By Geography-
The AI in pharma market is segmented by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the AI in pharma market, accounting for 43.2% of the total in 2020. It was followed by the Western Europe, Asia-Pacific and then the other regions. Going forward, the fastest-growing regions in the AI in pharma market will be South America and Asia Pacific where growth will be at CAGRs of 42.7% and 38.6% respectively during 2020-2025. These will be followed by Africa and Western Europe, where the markets are expected to register CAGRs of 35.77% and 34.72% respectively during 2020-2025.

AI In Pharma Competitive Landscape

Major Competitors In The AI In Pharma Market Are:

  • IBM Watson Health
  • Alphabet Inc.
  • Concreto HealthAI
  • Nvidia Corporation
  • PathAI
  • Other Competitors In The AI In Pharma Market Include:

  • Exscientia
  • Benevolent AI
  • BERG
  • OWKIN
  • Intel
  • Shanghai Pharmaceuticals
  • Standigm
  • Takeda Pharmaceutical Company Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • China National Pharmaceutical Group Co. Ltd. (Sinopharm)
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Cipla Limited
  • Aurobindo Pharma Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharma
  • Roche India
  • Alliance Pharm Pte Ltd.
  • GSK Australia
  • DeepMind
  • GlaxoSmithKline
  • Sanofi
  • Bayer
  • Renalytix AI
  • Merck
  • Iktos
  • BenevolentAI
  • Novartis
  • Gero
  • Ardigen
  • Insilico Medicine
  • Botkin
  • Webiomed
  • Care Mentor AI
  • Diagnocat
  • IBM Corporation
  • Google
  • Atomwise, Inc
  • Cloud Pharmaceuticals
  • Bioage
  • NuMedii
  • Envisagenics
  • Owkin, Inc.
  • XtalPi
  • Verge Genomics
  • Berg LLC
  • Deep Genomics (Canada)
  • Cyclica
  • Microsoft
  • Insilico Medicine
  • IQVIA
  • Roche
  • Novartis
  • Pfizer
  • PRA Healthscience
  • Gesto
  • Intensicare
  • Epitrack
  • GE Healthcare
  • Deep Genomics Inc.
  • Welltok Inc.
  • Oncora Medical
  • Recursion Pharmaceuticals Inc.
  • Nucleai
  • Pepticom
  • IBM Watson
  • AstraZeneca (South Africa)
  • Rology
  • hearX Group
  • DilenyTech
  • iNNOHEALTH Technology Solutions
    1. Table Of Contents

      1. AI In Pharma Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6.  Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Technology

      6.3. Segmentation By Drug Type

      6.4. Segmentation By Application

      7.   AI In Pharma Market Characteristics

      7.1. Market Definition

      7.2. Segmentation By Technology

      7.2.1. Context-Aware Processing

      7.2.2. Natural Language Processing

      7.2.3. Querying Method

      7.2.4. Deep Learning

      7.3. Market Segmentation By Drug Type

      7.3.1. Small Molecules

      7.3.2. Large Molecules

      7.4. Segmentation By Application

      7.4.1. Clinical Trial Research

      7.4.2. Drug Discovery

      7.4.3. Research And Development

      7.4.4. Others

      8.  AI In Pharma Market Trends And Strategies

      8.1. Use Of AI For Clinical Trials

      8.2. AI For Rare Diseases Treatment

      8.3. AI For Drug Adherence

      8.4. Investments in AI Driven Biotech Firms

      8.5. Rise In Merger And Acquisition Activity

      8.6. Introduction of New Artificial Intelligence (AI) Tools

      8.7. Emerging Role of CROs in AI Ecosystems

      8.8. Introduction of AI Innovation Labs

      9.  Impact Of COVID-19 On The AI In Pharma Market

      9.1. Introduction

      9.2. Use Of AI For Vaccine Development

      9.3. Clinical Trials

      9.4. Future Outlook

      10. Global AI In Pharma Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global AI In Pharma Market Segmentation

      11.1. Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2. Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.3. Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12. AI In Pharma Market, Regional And Country Analysis

      12.1. Global AI In Pharma Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global AI In Pharma Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific AI In Pharma Market

      13.1. Asia-Pacific AI In Pharma Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. COVID-19 Impact

      13.1.4. Background Information

      13.1.5. Government Initiatives

      13.1.6. Regulations

      13.1.7. Regulatory Bodies

      13.1.8. Major Associations

      13.1.9. Taxes levied

      13.1.10. Corporate Tax Structure

      13.1.11. Investments

      13.1.12. Major Companies

      13.2. Asia-Pacific AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3. Asia-Pacific AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.4. Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.6. Asia-Pacific AI In Pharma Market: Country Analysis

      13.7. China AI In Pharma Market

      13.8. China AI In Pharma Market Overview

      13.8.1. Country Information

      13.8.2. Market Information

      13.8.3. COVID-19 Impact

      13.8.4. Background Information

      13.8.5. Government Initiatives

      13.8.6. Regulations

      13.8.7. Regulatory Bodies

      13.8.8. Major Associations

      13.8.9. Taxes Levied

      13.8.10. Corporate Tax Structure

      13.8.11. Investments

      13.8.12. Major Companies

      13.9. China AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.10. China AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.11. China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.12. China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.13. India AI In Pharma Market

      13.14. India AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.15. India AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.16. India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.17. India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. Japan AI In Pharma Market

      13.19. Japan AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.20. Japan AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.21. Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.22. Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.23. Australia AI In Pharma Market

      13.24. Australia AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.25. Australia AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.26. Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.27. Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.28. Indonesia AI In Pharma Market

      13.29. Indonesia AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.30. Indonesia AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.31. Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.32. Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.33. South Korea AI In Pharma Market

      13.34. South Korea AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.35. South Korea AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.36. South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.37. South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe AI In Pharma Market

      14.1. Western Europe AI In Pharma Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. COVID-19 Impact

      14.1.4. Background Information

      14.1.5. Government Initiatives

      14.1.6. Regulations

      14.1.7. Regulatory Bodies

      14.1.8. Major Associations

      14.1.9. Taxes Levied

      14.1.10. Corporate Tax Structure

      14.1.11. Investments

      14.1.12. Major Companies

      14.2. Western Europe AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3. Western Europe AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.4. Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.6. Western Europe AI In Pharma Market: Country Analysis

      14.7. UK AI In Pharma Market

      14.8. UK AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.9. UK AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.10. UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.11. UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.12. Germany AI In Pharma Market

      14.13. Germany AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.14. Germany AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.15. Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.16. Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.17. France AI In Pharma Market

      14.18. France AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.19. France AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.20. France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.21. France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe AI In Pharma Market

      15.1. Eastern Europe AI In Pharma Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. COVID-19 Impact

      15.1.4. Background Information

      15.1.5. Government Initiatives

      15.1.6. Regulations

      15.1.7. Regulatory Bodies

      15.1.8. Major Associations

      15.1.9. Taxes Levied

      15.1.10. Corporate Tax Structure

      15.1.11. Investments

      15.1.12. Major Companies

      15.2. Eastern Europe AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3. Eastern Europe AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.4. Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5. Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.6. Eastern Europe AI In Pharma Market: Country Analysis

      15.7. Russia AI In Pharma Market

      15.8. Russia AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.9. Russia AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.10. Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.11. Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America AI In Pharma Market

      16.1. North America AI In Pharma Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. COVID-19 Impact

      16.1.4. Background Information

      16.1.5. Government Initiatives

      16.1.6. Regulations

      16.1.7. Regulatory Bodies

      16.1.8. Major Associations

      16.1.9. Taxes Levied

      16.1.10. Corporate Tax Structure

      16.1.11. Investments

      16.1.12. Major Companies

      16.2. North America AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3. North America AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.4. North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.6. North America AI In Pharma Market: Country Analysis

      16.7. USA AI In Pharma Market

      16.8. USA AI In Pharma Market Overview

      16.8.1. Country Information

      16.8.2. Market Information

      16.8.3. COVID-19 Impact

      16.8.4. Background Information

      16.8.5. Government Initiatives

      16.8.6. Regulations

      16.8.7. Regulatory Bodies

      16.8.8. Major Associations

      16.8.9. Taxes Levied

      16.8.10. Corporate Tax Structure

      16.8.11. Investments

      16.8.12. Major Companies

      16.9. USA AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.10. USA AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.11. USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.12. USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America AI In Pharma Market

      17.1. South America AI In Pharma Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. COVID-19 Impact

      17.1.4. Background Information

      17.1.5. Government Initiatives

      17.1.6. Regulations

      17.1.7. Regulatory Bodies

      17.1.8. Major Associations

      17.1.9. Taxes Levied

      17.1.10. Corporate Tax Structure

      17.1.11. Investments

      17.1.12. Major Companies

      17.2. South America AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.4. South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.6. South America AI In Pharma Market: Country Analysis

      17.7. Brazil AI In Pharma Market

      17.8. Brazil AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.9. Brazil AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.10. Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.11. Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East AI In Pharma Market

      18.1. Middle East AI In Pharma Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. COVID-19 Impact

      18.1.4. Background Information

      18.1.5. Government Initiatives

      18.1.6. Regulations

      18.1.7. Regulatory Bodies

      18.1.8. Major Associations

      18.1.9. Taxes Levied

      18.1.10. Corporate Tax Structure

      18.1.11. Investments

      18.1.12. Major Companies

      18.2. Middle East AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3. Middle East AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.4. Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa AI In Pharma Market

      19.1. Africa AI In Pharma Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. COVID-19 Impact

      19.1.4. Background Information

      19.1.5. Government Initiatives

      19.1.6. Regulations

      19.1.7. Regulatory Bodies

      19.1.8. Major Associations

      19.1.9. Taxes levied

      19.1.10. Corporate Tax Structure

      19.1.11. Investments

      19.1.12. Major Companies

      19.2. Africa AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3. Africa AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.4. Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.5. Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Global AI In Pharma Market Competitive Landscape

      20.1. Company Profiles

      20.2. IBM Watson Health

      20.2.1. Company Overview

      20.2.2. Products And Services.

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Alphabet Inc.

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Concreto HealthAI

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Nvidia Corporation

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. PathAI

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Key Mergers And Acquisitions In The AI In Pharma Market

      21.1. Charles River Laboratories Acquired Distributed Bio

      21.2. Exscientia Acquired Austrian Company Allcyte

      21.3. Valo Health merged with Khosla Ventures Acquisition

      21.4. PathAI Merged with Labcorp

      22. AI In Pharma Market Future Outlook and Potential Analysis

      22.1. Global AI In Pharma Market In 2025 – Countries Offering Most New Opportunities

      22.2. Global AI In Pharma Market In 2025 – Segments Offering Most New Opportunities

      22.3. Global AI In Pharma Market In 2025 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. Appendix

      23.1. Market Data Sources

      23.2. Research Methodology

      23.3. Currencies

      23.4. Research Inquiries

      23.5. The Business Research Company

      23.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global AI In Pharma Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global AI In Pharma Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Global AI In Pharma Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 12: Global AI In Pharma Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 13: Asia-Pacific Vaccine Market, COVID-19 Vaccines Approvals
    • Table 14: Asia-Pacific Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 15: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 16: Asia-Pacific Pharmaceuticals Industry Market Size, 2015-2025, $ Billion
    • Table 17: Asia Pacific Biologics Market Size, 2015-2025, $ Billion
    • Table 18: Asia Pacific Software Products Market Size, 2015-2025, $ Billion
    • Table 19: Asia-Pacific AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 20: Asia-Pacific AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 21: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 22: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 23: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 24: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 25: China Vaccine Market, COVID-19 Vaccines Approvals
    • Table 26: China GDP Per Capita, 2015-2020, $
    • Table 27: China, Pharmaceuticals Industry Market Size, 2015-2025, $ Billion
    • Table 28: China Biologics Market Size, 2015-2025, $ Billion
    • Table 29: China Software Products Market Size, 2015-2025, $ Billion
    • Table 30: China AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 31: China AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 32: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 33: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 34: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 35: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 36: India AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 37: India AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 38: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 39: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 40: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 41: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 42: Japan AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 43: Japan AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 44: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 45: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 46: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 47: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 48: Australia AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 49: Australia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 50: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 51: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 52: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 53: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 54: Indonesia AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 55: Indonesia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 56: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 57: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 58: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 59: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 60: South Korea AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 61: South Korea AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 62: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 63: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 64: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 65: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 66: Western Europe AI In Pharma Market, COVID-19 Vaccines Approvals
    • Table 67: Western Europe AI In Pharma Market, Number of COVID-19 Doses Administered, By Country
    • Table 68: Western Europe GDP Per Capita, 2015-2020, $
    • Table 69: Western Europe, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 70: Western Europe Biologics Market Size, 2015-2025, $ Billion
    • Table 71: Western Europe Software Products Market Size, 2015-2025, $ Billion
    • Table 72: Western Europe AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 73: Western Europe AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 74: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 75: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 76: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 77: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 78: UK AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 79: UK AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 80: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 81: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 82: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 83: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 84: Germany AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 85: Germany AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 86: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 87: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 88: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 89: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 90: France AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 91: France AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 92: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 93: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 94: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 95: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 96: Western Europe AI In Pharma Market, COVID-19 Vaccines Approvals
    • Table 97: Eastern Europe AI In Pharma Market, Number of COVID-19 Doses Administered, By Country
    • Table 98: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 99: Eastern Europe, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 100:Eastern Europe Biologics Market Size, 2015-2025, $ Billion
    • Table 101:Eastern Europe Software Products Market Size, 2015-2025, $ Billion
    • Table 102: Eastern Europe AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 103: Eastern Europe AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 104: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 105: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 106: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 107: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 108: Russia AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 109: Russia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 110: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 111: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 112: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 113: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 114: North America Vaccine Market, COVID-19 Vaccines Approvals
    • Table 115: North America Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 116: North America GDP Per Capita, 2015-2020, $
    • Table 117: North America, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 118: North America Biologics Market Size, 2015-2025, $ Billion
    • Table 119: North America Software Products Market Size, 2015-2025, $ Billion
    • Table 120: North America AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 121: North America AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 122: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 123: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 124: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 125: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 126: USA Vaccine Market, COVID-19 Vaccines Approvals
    • Table 127: USA GDP Per Capita, 2015-2020, $
    • Table 128: USA Home, Pharmaceuticals Industry Market Size, 2015-2025, $ Billion
    • Table 129: USA Biologics Market Size, 2015-2025, $ Billion
    • Table 130: USA Biologics Market Size, 2015-2025, $ Billion
    • Table 131: USA AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 132: USA AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 133: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 134: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 135: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 136: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 137: South America Vaccine Market, COVID-19 Vaccines Approvals
    • Table 138: South America Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 139: South America GDP Per Capita, 2015-2020, $
    • Table 140: South America, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 141: South America Biologics Market Size, 2015-2025, $ Billion
    • Table 142: South America Software Products Market Size, 2015-2025, $ Billion
    • Table 143: South America AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 144: South America AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 145: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 146: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 147: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 148: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 149: Brazil AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 150: Brazil AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 151: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 152: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 153: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 154: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 155: Middle East Vaccine Market, COVID-19 Vaccines Approvals
    • Table 156: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 157: Middle East GDP Per Capita, 2015-2020, $
    • Table 158: Middle East Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 159: Middle East Biologics Market Size, 2015-2025, $ Billion
    • Table 160: Western Europe Biologics Market Size, 2015-2025, $ Billion
    • Table 161: Middle East AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 162: Middle East AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 163: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 164: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 165: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 166: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 167: Africa AI In Pharma Market, COVID-19 Vaccines Approvals
    • Table 168: Africa AI In Pharma Market, Number of COVID-19 Doses Administered, By Country
    • Table 169: Africa GDP Per Capita, 2015-2020, $
    • Table 170: Africa Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 171: Africa Biologics Market Size, 2015-2025, $ Billion
    • Table 172: Africa Biologics Market Size, 2015-2025, $ Billion
    • Table 173: Africa AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Table 174: Africa AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 175: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 176: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 177: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 178: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 179: Global AI In Pharma Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 180: IBM Watson Health – Financial Overview, 2016 - 2020, $ Billion
    • Table 181: Alphabet Inc. – Financial Overview, 2016 - 2020, $ Billion
    • Table 182: Nvidia Corporation – Financial Overview, 2016 - 2020, $ Billion
    • Table 183: Global AI In Pharma Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 184: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Technology, 2020 – 2025
    • Table 185: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Drug Type, 2020 – 2025
    • Table 186: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
    • Table 187: Artificial Intelligence (AI) In Pharma - Market Data Sources

    List Of Figures

      Figure 1: Global Artificial Intelligence (AI) In Pharma Market Segmentation By Geography
    • Figure 2: Global Artificial Intelligence (AI) In Pharma Market Segmentation By Technology
    • Figure 3: Global Artificial Intelligence (AI) In Pharma Market Segmentation By Drug Type
    • Figure 4: Global AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 5: Global AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 6: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 8: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Global AI In Pharma Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global AI In Pharma Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Asia-Pacific AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 12: Asia-Pacific AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 13: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: China AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 16: China AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 17: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 18: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 19: India AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 20: India AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 21: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Japan AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Japan AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Australia AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 28: Australia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 29: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: Indonesia AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 32: Indonesia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: South Korea AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 36: South Korea AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 37: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 39: Western Europe AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 40: Western Europe AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 41: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: UK AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 44: UK AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 45: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 47: Germany AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 48: Germany AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 49: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: France AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 52: France AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 53: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 55: Eastern Europe AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 56: Eastern Europe AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 57: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 59: Russia AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 60: Russia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 61: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 63: North America AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 64: North America AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 65: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 67: USA AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 68: USA AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 69: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 71: South America AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 72: South America AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 73: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 74: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: Brazil AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 76: Brazil AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 77: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 79: Middle East AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 80: Middle East AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 81: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 83: Africa AI In Pharma Market, Historic, 2015 – 2020, $ Million
    • Figure 84: Africa AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 85: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 86: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 87: Global AI In Pharma Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 88: IBM Watson Health – Financial Overview, 2016 – 2020, $ Billion
    • Figure 89: Alphabet Inc. – Financial Overview, 2016 – 2020, $ Billion
    • Figure 90: Nvidia Corporation – Financial Overview, 2016 – 2020, $ Billion
    Global Cybersecurity Services Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Wired Telecommunication Carriers Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Wireless Telecommunication Carriers Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Wireless Internet Services Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Virtual Reality Services Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Product Lifecycle Management Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Radiofrequency Identification (RFID) Tags Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Video Conferencing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    3D Printed Prosthetics Global Market Report 2021 - By Material (Polypropylene, Polyethylene, Acrylics, Polyurethane), By Type (Sockets, Limbs, Joints, Covers), By End-User (Hospitals, Rehabilitation Centers, Prosthetic Clinics), COVID-19 Growth And Change
    View Report
    Artificial Intelligence (AI) In Drug Discovery Global Market Report 2021 - By Technology (Deep Learning, Machine Learning), By Drug Type (Small Molecule, Large Molecules), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases), By End-Users (Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes), COVID-19 Growth And Change
    View Report
    CRISPR Technology Global Market Report 2021 - By Product Type (Design Tools, Plasmid And Vector, Cas9 And G-RNA, Delivery System Products), By Application (Genome Editing/ Genetic Engineering, Genetically Modified Organisms, Agricultural Biotechnology), By End-User (Industrial Biotech, Biological Research, Agricultural Research, Therapeutics And Drug Discovery), COVID-19 Growth And Change
    View Report
    Biophotonics Global Market Report 2021 - By Product Technology (In-Vitro, In-Vivo), By Application (See-Through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors), By End Use (Diagnostics, Therapeutic, Tests), COVID-19 Growth And Change
    View Report
    Biosimilars Global Market Report 2021 - By Product (Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins), By Types (Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases), COVID-19 Growth And Change
    View Report
    Synthetic Biology Global Market Report 2021 - By Technology (Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering), By Application (Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics), By Product Type (Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism), COVID-19 Growth And Change
    View Report
    3D Cell Culture Technologies Global Market Report 2021 - By Type (Scaffold-Based, Scaffold-Free, 3D Bioreactors), By End Users (Research Laboratories And Institutes, Biotechnology And Pharmaceutical Companies, Hospitals and Diagnostic Centers), By Scaffold-Based (Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates), By Scaffold-Free (Hanging Drop Microplates, Spheroid Microplates, Microfluidic 3D Cell Culture, Magnetic Levitations & 3D Bioprinting), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine), COVID-19 Growth And Change
    View Report
    3D Printed Implants Global Market Report 2021 - By Application (Dental, Orthopedic, Cranio-maxillofacial), By End Users (Medical And Surgical Centers, Pharmaceutical Companies, Biotechnology Industry, Medical Institution), By Implantation Technology (Laser Beam Melting, Electronic Beam Melting, Droplet Deposition, Laminated Deposition, Two-Photon Polymerization), COVID-19 Growth And Change
    View Report

    Call Us

    +1 3156230293

    (Americas)

    +44 2071930708

    (Europe)

    +91 8897263534

    (Asia & Others)